PharmaCyte completes gene integration assay, IND progresses for LAPC
PharmaCyte Biotech has released the results of an additional, more detailed analysis of the integration site of the cytochrome P450 2B1 gene from the augmented HEK293 cell line clone that PharmaCyte uses in its CypCap product. This assay is required by the U.S. Food and Drug Administration (FDA) to lift the clinical hold on PharmaCyte's investigational new drug (IND) application for the treatment of inoperable locally advanced pancreatic cancer (LAPC). Read More
PacBio, UCLA announce research collaboration
Pacific BioSciences (PacBio), the Institute for Precision Health at the University of California, Los Angeles (UCLA), and UCLA's David Geffen School of Medicine have formed a research collaboration to further identify the causes of rare diseases. The collaboration aims to identify variants not easily detectable by short-read sequencing. Read More
Recursion, Roche, Genentech to use machine learning, HCS to drive discovery
Recursion is set to collaborate with Roche and Genentech in the fields of neuroscience and oncology to advance new medicines for patients using large-scale machine-learning and high-content screening (HCS) methods to map complex biology. Read More
Yokogawa develops single cellome system for subcellular sampling
Yokogawa Electric unveiled the single cellome system SS2000, a single-cell analysis solution that automatically collects samples of specific cells and intracellular components. The SS2000 will be released in Japan, the U.S., and China in February 2022, and later in Europe. Read More
Parallel Fluidics secures $1.8M in funding round
Digital microfluidic devices manufacturer Parallel Fluidics has garnered $1.8 million in a new round of financing from a syndicate of investors, founders, and technologists. Read More
Earlham Institute deploys new HiFi platform
The Earlham Institute in Norwich, U.K., has implemented a twin set of Pacific Biosciences' Sequel IIe platform to increase its support for the Earth BioGenome projects. Read More
Mission Bio touts study about its Tapestri platform
Mission Bio announced that its Tapestri platform helped elucidate resistance mechanisms to lung cancer drugs. Researchers from Memorial Sloan Kettering Cancer Center detail the discovery of these resistance mechanisms in a study that was published November 10 in Nature. Read More
LevitasBio debuts sample preparation, cell enrichment product lines
LevitasBio has introduced new tissue dissociation reagent kits and target depletion assays designed to help researchers and laboratory personnel better process and characterize human, animal, and plant samples. Read More
Startups selected for Illumina's genomics incubator in China
Illumina and investment firm Sequoia Capital China have selected the first two startups to join the Sequoia Capital China Intelligent Healthcare Genomics Incubator located in Zhangjiang Cell Industrial Park, Shanghai. Read More
5 takeaways from SITC 2021
WASHINGTON, DC - The Society for Immunotherapy of Cancer's (SITC) 2021 annual meeting November 10-14 was a successful gathering of research and clinical experts focused on the development of innovative cancer treatments. The ScienceBoard team was live onsite at the event. Editor in Chief Samantha Black, PhD, shared five takeaways from the meeting. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter